Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma: Symptoms, Causes, Types, Diagnosis, and Treatments

Non-Hodgkin lymphoma (NHL) is a diverse group of blood cancers that affect the lymphatic system—a critical part of the immune system. Unlike Hodgkin lymphoma, NHL lacks a specific type of abnormal cell called the Reed-Sternberg cell. This type of cancer can develop in lymph nodes anywhere in the body and may also affect organs like the liver, spleen, or bone marrow.

In this comprehensive article, we will explore everything you need to know about Non-Hodgkin lymphoma, including its symptoms, underlying causes, different types, diagnostic procedures, and treatment options.

---

What is Non-Hodgkin Lymphoma?

Non-Hodgkin lymphoma refers to a group of blood cancers originating in the lymphocytes, a type of white blood cell responsible for fighting infection. Lymphocytes are part of the lymphatic system, which includes lymph nodes, spleen, thymus gland, and bone marrow. When these cells grow uncontrollably, they can form tumors and affect immune function.

Unlike many cancers, NHL does not remain localized. It often spreads in a non-orderly fashion to various parts of the body, including extranodal sites (outside the lymph nodes).

---

Key Differences Between Hodgkin and Non-Hodgkin Lymphoma

Feature	Hodgkin Lymphoma	Non-Hodgkin Lymphoma
Cell Type	Reed-Sternberg cells present	Reed-Sternberg cells absent
Spread Pattern	Orderly from one lymph node to another	Non-orderly spread
Common Age Group	Young adults and elderly	More common in older adults
Prognosis	Generally good	Varies widely depending on type

---

Symptoms of Non-Hodgkin Lymphoma

The symptoms of NHL may be subtle initially, and they often resemble those of less serious conditions. However, persistent symptoms should not be ignored.

Common Symptoms Include:

• Swollen Lymph Nodes: Typically painless and located in the neck, armpits, or groin.
• Unexplained Weight Loss: Loss of more than 10% body weight over 6 months.
• Fever: Often without any apparent infection.
• Night Sweats: Drenching sweats that disrupt sleep.
• Fatigue: Persistent tiredness not relieved by rest.
• Abdominal Pain or Swelling: If lymph nodes or organs in the abdomen are involved.
• Chest Pain or Coughing: When lymph nodes in the chest are enlarged.
• Frequent Infections: Due to compromised immunity.

B Symptoms:

In NHL, some patients experience “B symptoms” that can indicate a more aggressive form:

• Fever
• Night sweats
• Unexplained weight loss

---

Causes and Risk Factors

The exact cause of Non-Hodgkin lymphoma is unknown, but several risk factors have been identified.

1. Age and Gender

• Most cases occur in people over the age of 60.
• Slightly more common in men than women.

2. Weakened Immune System

• People with HIV/AIDS, organ transplant recipients, or those taking immunosuppressive drugs are at increased risk.

3. Autoimmune Diseases

• Conditions like lupus or rheumatoid arthritis can elevate risk.

4. Infections

• Epstein-Barr Virus (EBV) and Helicobacter pylori are associated with certain types of NHL.
• Human T-cell leukemia virus (HTLV-1) is linked to rare types.

5. Chemical Exposure

• Long-term exposure to herbicides, pesticides, or industrial solvents may increase risk.

6. Radiation Exposure

• Survivors of nuclear accidents or high-dose radiation therapy are at a higher risk.

7. Family History

• A first-degree relative with NHL slightly raises risk.

---

Types of Non-Hodgkin Lymphoma

There are over 60 types of NHL, typically classified by the cell type (B-cell or T-cell) and growth rate (indolent or aggressive).

A. B-cell Lymphomas (Most Common)

1. Diffuse Large B-cell Lymphoma (DLBCL)

• Most common aggressive type.
• Rapid-growing but potentially curable.

2. Follicular Lymphoma

• Second most common.
• Slow-growing (indolent), but may become aggressive.

3. Mantle Cell Lymphoma

• Rare and aggressive.
• Typically affects men over 60.

4. Burkitt Lymphoma

• Very fast-growing.
• Common in children and young adults.

5. Marginal Zone Lymphoma

• Indolent.
• Often associated with chronic infections like H. pylori.

B. T-cell Lymphomas (Less Common)

1. Peripheral T-cell Lymphoma (PTCL)

• Aggressive and often harder to treat.

2. Cutaneous T-cell Lymphoma

• Starts in the skin.
• Mycosis fungoides is the most common subtype.

3. Anaplastic Large Cell Lymphoma (ALCL)

• Aggressive; may affect lymph nodes and skin.

---

Diagnosis of Non-Hodgkin Lymphoma

Early diagnosis improves treatment outcomes significantly. A combination of physical exams, lab tests, and imaging is used.

1. Physical Examination

• Checks for swollen lymph nodes and organ enlargement.

2. Blood Tests

• Complete Blood Count (CBC)
• Liver and kidney function tests
• LDH (lactate dehydrogenase) levels (may indicate disease severity)

3. Imaging Tests

• CT Scan: Helps locate affected lymph nodes or organs.
• PET Scan: Shows areas of high metabolic activity.
• MRI: Useful in specific cases like central nervous system (CNS) involvement.

4. Lymph Node Biopsy

• A definitive diagnostic test.
• Tissue sample is examined for abnormal lymphocytes.

5. Bone Marrow Biopsy

• Determines if the bone marrow is involved.

6. Lumbar Puncture

• Done if there’s a suspicion of CNS lymphoma.

7. Molecular and Genetic Testing

• Identifies specific subtypes and genetic mutations for targeted therapy.

---

Staging of Non-Hodgkin Lymphoma

Staging helps guide treatment and predict prognosis. It ranges from I to IV based on spread.

• Stage I: One lymph node region or single organ.
• Stage II: Two or more regions on the same side of the diaphragm.
• Stage III: Lymph nodes on both sides of the diaphragm.
• Stage IV: Involvement of distant organs like liver, bone marrow, or CNS.

---

Treatment Options for Non-Hodgkin Lymphoma

Treatment depends on the type, stage, and individual health factors. Options range from watchful waiting to intensive chemotherapy.

1. Watchful Waiting

• For indolent forms without symptoms.
• Regular monitoring without immediate treatment.

2. Chemotherapy

• CHOP Regimen: Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
• Often combined with Rituximab (R-CHOP).

3. Immunotherapy

• Monoclonal Antibodies: Rituximab (targets CD20 on B-cells).
• CAR T-cell Therapy: T-cells are engineered to attack cancer cells.
• Checkpoint Inhibitors: Boost the immune response.

4. Targeted Therapy

• Drugs that block specific molecules involved in cancer growth.
• Examples: Ibrutinib, Venetoclax, Idelalisib.

5. Radiation Therapy

• Used in localized disease or to shrink large tumors.

6. Stem Cell Transplant

• Autologous Transplant: Uses patient’s own stem cells.
• Allogeneic Transplant: From a donor.
• Used in recurrent or aggressive NHL.

7. Surgery

• Rarely used, except for diagnosis or removal of isolated tumors.

---

Prognosis and Survival Rates

The prognosis depends on several factors:

• Type and stage of NHL
• Age and overall health
• Response to treatment
• Presence of B symptoms
• LDH levels

Survival Rates:

According to the American Cancer Society:

• 5-Year Survival Rate: ~73%
• Indolent types: Often long-term survival even without cure.
• Aggressive types: May be curable with intensive therapy.

---

Living with Non-Hodgkin Lymphoma

1. Follow-up Care

• Regular exams and imaging.
• Blood tests to detect relapse.

2. Managing Side Effects

• Fatigue, nausea, infections, neuropathy.
• Supportive therapies like pain management and nutritional support.

3. Psychological Support

• Counseling and support groups.
• Addressing anxiety, depression, and coping mechanisms.

4. Lifestyle Modifications

• Healthy diet and regular exercise.
• Avoiding infections through hygiene and vaccinations.

---

Prevention and Early Detection

While there is no guaranteed way to prevent NHL, reducing risk factors can help.

Tips for Prevention:

• Avoid exposure to harmful chemicals.
• Practice safe sex and avoid IV drug use to reduce infection risk.
• Treat chronic infections promptly.
• Manage autoimmune disorders effectively.
• Routine medical checkups for high-risk individuals.

---

Conclusion

Non-Hodgkin lymphoma is a complex and varied group of cancers with different outcomes based on type, stage, and treatment approach. Thanks to advances in medical research, many patients with NHL live long, fulfilling lives after diagnosis. Early detection, personalized treatment, and a strong support system are key to managing the disease effectively.

If you or someone you know is experiencing symptoms of NHL, consult a healthcare provider immediately. Timely diagnosis and tailored therapy can make all the difference.

Frequently Asked Questions (FAQs) About Non-Hodgkin Lymphoma

For more details keep visiting our Website & Facebook Page.